PAIN THERAPEUTICS INC's ticker is PTIE and the CUSIP is 69562K100.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $22,000 | +46.7% | 25,348 | 0.0% | 0.00% | – |
| Q4 2016 | $15,000 | -34.8% | 25,348 | -0.7% | 0.00% | – |
| Q3 2016 | $23,000 | -72.6% | 25,528 | -33.3% | 0.00% | – |
| Q2 2016 | $84,000 | -7.7% | 38,247 | -6.4% | 0.00% | – |
| Q1 2016 | $91,000 | +24.7% | 40,845 | 0.0% | 0.00% | – |
| Q4 2015 | $73,000 | -5.2% | 40,845 | -2.6% | 0.00% | – |
| Q3 2015 | $77,000 | -16.3% | 41,928 | -20.8% | 0.00% | – |
| Q2 2015 | $92,000 | -88.3% | 52,928 | -87.2% | 0.00% | – |
| Q1 2015 | $783,000 | +3.7% | 414,129 | +11.6% | 0.00% | – |
| Q4 2014 | $755,000 | -47.4% | 371,203 | +1.2% | 0.00% | – |
| Q3 2014 | $1,435,000 | -31.9% | 366,761 | +0.2% | 0.00% | – |
| Q2 2014 | $2,107,000 | +1277.1% | 366,038 | +1215.4% | 0.00% | – |
| Q1 2014 | $153,000 | -91.7% | 27,828 | -95.8% | 0.00% | – |
| Q4 2013 | $1,838,000 | +1684.5% | 656,793 | +1640.9% | 0.00% | – |
| Q3 2013 | $103,000 | +12.0% | 37,728 | -9.4% | 0.00% | – |
| Q2 2013 | $92,000 | – | 41,628 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 2,797,689 | $13,597,000 | 9.60% |
| SOPHROSYNE CAPITAL LLC | 1,265,020 | $6,147,000 | 5.38% |
| Madison Street Partners, LLC | 976,653 | $4,747,000 | 4.46% |
| INTREPID CAPITAL MANAGEMENT INC /DE/ | 460,000 | $2,236,000 | 2.28% |
| Broadfin Capital, LLC | 1,230,000 | $5,978,000 | 0.79% |
| 683 Capital Management, LLC | 427,071 | $2,076,000 | 0.59% |
| AVALON CAPITAL MANAGEMENT | 138,520 | $673,000 | 0.57% |
| Cheyne Capital Management (UK) LLP | 92,700 | $451,000 | 0.49% |
| Visium Asset Management, LP | 4,350,000 | $21,141,000 | 0.42% |
| Gruss Capital Management LP | 789,811 | $3,838,000 | 0.29% |